Loading presentation...

Present Remotely

Send the link below via email or IM

Copy

Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.

DeleteCancel

Make your likes visible on Facebook?

Connect your Facebook account to Prezi and let your likes appear on your timeline.
You can change this under Settings & Account at any time.

No, thanks

JOHNSON & JOHNSON FRAUD CASE

No description
by

寺脇 友紀

on 10 July 2015

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of JOHNSON & JOHNSON FRAUD CASE

Main points for litigation:
Case Details (2012 / 2013)
2012-2014 FRAUD CASES
Closing analysis
WHAT'S
・Founded in
1886

129,000
employees
・more than
250
operating subsidiaries,
in
125
countries
・$123,600 sales per second
a
$188 billion dollar
business
・Net income: $9.7 billion (2011)
・Revenue: $65.03 billion (2011)

ABOUT
Eugene Song
Rina Kodama
Venera Raneva

Yuki Terawaki
Ami Tozawa
Tsubasa Nakano
In 2012, Johnson & Johnson and subsidiary company Janssen were fined
$1.2 BILLION
in fines by an Arkansas judge for marketing that "violated
Medicare fraud laws
and Arkansas
deceptive trade practice statutes
."

In November of 2013, the U.S. Department of Justice ordered J&J to pay more than
$2.2 BILLION
for allegations that include
off-label marketing
and
kickbacks
to doctors and pharmacists.
a subsidiary of J&J
Arkansas Court Reversal (2014)
However, the 1.2 billion dollar on March 20th, 2014 the states
decision was reversed
by the Arkansas Supreme Court

Arkansas had
relied on the wrong law
to sue Johnson & Johnson, using a law covering healthcare facilities rather than drug companies.


1. J&J marketed the medicine
” for “unapproved uses
, including various symptoms in children and the elderly,” despite being
warned by the government to stop
.

2. J&J was accused of
hiding
. Weight gain, increased likelihood of diabetes, and increased risk of stroke in the elderly are all
possible adverse side effects
of Risperdal.

3. J&J claimed Risperdal was a
superior drug
and worth its hefty price tag, when in reality
it was not better
than the cheaper generic alternatives.

Sources
http://candidaabrahamson.wordpress.com/2012/08/08/three-biggest-pharmaceutical-lawsuits-of-2012-psychiatric-drugs-focus-of-all-three/
http://www.bloomberg.com/news/2012-04-11/jnj-told-to-pay-1-1-billion-penalty-in-arkansas-risperdal-trial.html
http://www.nytimes.com/2014/03/21/business/arkansas-court-reverses-1-2-billion-judgment-against-johnson-johnson.html?_r=0
http://www.nytimes.com/2012/04/12/business/drug-giant-is-fined-1-2-billion-in-arkansas.html?_r=0
http://www.reuters.com/article/2014/03/20/us-johnson-johnson-risperdal-lawsuit-idUSBREA2J1KK20140320
http://www.justice.gov/opa/pr/2013/November/13-ag-1170.html
http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=475100
http://www.justice.gov/opa/documents/jj/janssen-info.pdf

"a long-term mental disorder of a type involving a breakdown in the relation between thought, emotion, and behaviour, leading to faulty perception, inappropriate actions and feelings, withdrawal from reality and personal relationships into fantasy and delusion, and a sense of mental fragmentation."
Risperidone (Risperdal) is an antipsychotic drug mainly used to treat schizophrenia (including adolescent schizophrenia), schizoaffective disorder, the mixed and manic states of bipolar disorder, and irritability in people with autism, manufactured primarily by the pharmaceutical company Janssen.
What's Schizophrenia?
What's Risperdal?
J&J v State of Arkansas

This is “a big win for Arkansas,” said Arkansas Attorney General Dustin McDaniel. “These two companies [Johnson and Johnson and subsidiary Janssen]
put profits before people
, and they are rightfully being held responsible for their actions.” (2012)

In a statement, Dustin McDaniel, Arkansas’s attorney general, said he believed the State Legislature gave his office the authority to pursue penalties against companies like Johnson & Johnson. “I am disappointed that
the court viewed the law differently,
” he said. (2014 reversal)
SO WHAT DOES THIS HAVE TO DO WITH

?
UNITED STATES OF AMERICA
v
JANSSEN PHARMACEUTICAL, INC

&

JOHNSON & JOHNSON, INC.
v
STATE OF ARKANSAS

Janssen Pharmaceuticals v United States of America

“When pharmaceutical companies interfere with the FDA’s mission of ensuring that drugs are safe and effective for the American public, they undermine the doctor-patient relationship and
put the health and safety of patients at risk
,”

“Today’s settlement demonstrates the government’s continued focus on pharmaceutical companies that put profits ahead of the public’s health. The FDA will continue to devote resources to criminal investigations targeting pharmaceutical companies that
disregard the drug approval process
and recklessly
promote drugs for uses that have not been proven to be safe and effective
.”
Full transcript